Towfigh H
Handchir Mikrochir Plast Chir. 1983 Mar;15(1):61-3.
Ergotamine is used today for the symptomatic treatment of migraine. It is known that the intake of ergotamine-containing medicaments in cases of migraine causes disturbance of the blood-flow to the peripheral arteries of the extremities. Most of these spastic occlusions are due to medicaments containing ergotamine tartrate. Thus, ergotism is one of the frequent causes of spastic occlusion. The symptoms of blood-flow disturbances due to ergotamines do not differ from other geneses. Extreme cases develop gangrene of the finger tips, leading to a wrong diagnosis and subsequent amputation. A careful history and arteriography showing smooth stenoses usually give the correct diagnosis. An antidote to ergotamine is not known but the spastic occlusion and the neuropsychiatric complications are usually gone some days after the ergotamine-containing substance is discontinued. Anticoagulants and low-molecular dextran are indicated in order to prevent irreversible thrombosis.
麦角胺如今用于偏头痛的对症治疗。众所周知,偏头痛患者摄入含麦角胺的药物会导致四肢外周动脉血流紊乱。这些痉挛性闭塞大多归因于含酒石酸麦角胺的药物。因此,麦角中毒是痉挛性闭塞的常见原因之一。麦角胺引起的血流紊乱症状与其他病因并无不同。极端情况下会出现指尖坏疽,导致误诊及后续截肢。详细的病史和显示平滑狭窄的血管造影通常能得出正确诊断。目前尚无麦角胺的解毒剂,但在停用含麦角胺的物质几天后,痉挛性闭塞和神经精神并发症通常会消失。为防止不可逆血栓形成,可使用抗凝剂和低分子右旋糖酐。